Kai Yan Mak

581 total citations
9 papers, 338 citations indexed

About

Kai Yan Mak is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kai Yan Mak has authored 9 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kai Yan Mak's work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease and Transplantation (3 papers). Kai Yan Mak is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease and Transplantation (3 papers). Kai Yan Mak collaborates with scholars based in Australia, Denmark and Singapore. Kai Yan Mak's co-authors include Chandana B. Herath, Peter Angus, Louise M. Burrell, Josephine Grace, Zhiyuan Jia, Josephine M. Forbes, Christopher Leung, Matthew J. Watt, Ping Huang and Alexandra F. Sharland and has published in prestigious journals such as Journal of Virology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Kai Yan Mak

9 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai Yan Mak Australia	8	149	103	94	87	66	9	338
Marta Flisiak‐Jackiewicz Poland	10	262 1.8×	99 1.0×	110 1.2×	53 0.6×	76 1.2×	22	347
Marieke Velema Netherlands	10	102 0.7×	64 0.6×	156 1.7×	19 0.2×	20 0.3×	14	343
C. Camcı Türkiye	10	52 0.3×	68 0.7×	50 0.5×	56 0.6×	30 0.5×	23	331
Rumi Mifuji‐Moroka Japan	13	184 1.2×	142 1.4×	28 0.3×	20 0.2×	110 1.7×	20	439
Á. Estébanez Spain	7	270 1.8×	86 0.8×	46 0.5×	31 0.4×	114 1.7×	10	344
Congxiang Shao China	12	282 1.9×	93 0.9×	132 1.4×	35 0.4×	89 1.3×	23	333
Mervat Naguib Egypt	10	154 1.0×	102 1.0×	37 0.4×	11 0.1×	53 0.8×	28	313
Erika Paolini Italy	10	263 1.8×	78 0.8×	101 1.1×	43 0.5×	130 2.0×	27	407
Abdel R.A. Hamad United States	11	150 1.0×	28 0.3×	36 0.4×	39 0.4×	192 2.9×	13	560
Junzhao Ye China	15	481 3.2×	169 1.6×	206 2.2×	61 0.7×	123 1.9×	49	589

Countries citing papers authored by Kai Yan Mak

Since Specialization

Citations

This map shows the geographic impact of Kai Yan Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Yan Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Yan Mak more than expected).

Fields of papers citing papers by Kai Yan Mak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Yan Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Yan Mak. The network helps show where Kai Yan Mak may publish in the future.

Co-authorship network of co-authors of Kai Yan Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Yan Mak. A scholar is included among the top collaborators of Kai Yan Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Yan Mak. Kai Yan Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sozzi, Vitina, et al.. (2024). The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of Virology. 98(4). e0153823–e0153823. 5 indexed citations

Casey, Stephen, Robert Schierwagen, Kai Yan Mak, et al.. (2019). Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation. Journal of Clinical Medicine. 8(4). 419–419. 25 indexed citations

Mak, Kai Yan, et al.. (2018). The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice. Scientific Reports. 8(1). 10175–10175. 39 indexed citations

Mak, Kai Yan, et al.. (2017). The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders. Current Gene Therapy. 17(1). 4–16. 25 indexed citations

Mak, Kai Yan, Ruth Chin, Sharon C. Cunningham, et al.. (2015). ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice. Molecular Therapy. 23(9). 1434–1443. 53 indexed citations

Leung, Christopher, Chandana B. Herath, Zhiyuan Jia, et al.. (2013). Dietary glycotoxins exacerbate progression of experimental fatty liver disease. Journal of Hepatology. 60(4). 832–838. 75 indexed citations

Herath, Chandana B., Kai Yan Mak, Louise M. Burrell, & Peter Angus. (2012). Angiotensin-(1–7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 304(1). G99–G108. 23 indexed citations

Grace, Josephine, Chandana B. Herath, Kai Yan Mak, Louise M. Burrell, & Peter Angus. (2012). Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options. Clinical Science. 123(4). 225–239. 80 indexed citations

Prabhakaran, K., Aileen Wee, D.S. Sutedja, et al.. (2004). Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant. Transplantation Proceedings. 36(8). 2313–2314. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact